Join
Live feed
·
INSIDERFilingvia Quantisnow
Ligand Pharmaceuticals Incorporated logo

Chief Financial Officer Espinoza Octavio acquired $765 worth of shares (8 units at $95.68), increasing direct ownership by 0.03% to 28,575 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LGND· Ligand Pharmaceuticals Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LGND (Ligand Pharmaceuticals Incorporated) and more on Quantisnow.

Chief Financial Officer Espinoza Octavio acquired $765 worth of shares (8 units at $95.68), increasing direct ownership by 0.03% to 28,575 units (SEC Form 4) | Quantisnow